Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management. [electronic resource]
Producer: 20201009Description: 1152-1160 p. digitalISSN:- 1097-0142
- Age Factors
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Brain Neoplasms -- prevention & control
- Constipation -- chemically induced
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Dexamethasone -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Monitoring -- methods
- Fusion Proteins, bcr-abl -- antagonists & inhibitors
- Genetic Predisposition to Disease
- Humans
- Injections, Spinal
- Intercellular Signaling Peptides and Proteins -- therapeutic use
- Kidney -- drug effects
- Methotrexate -- administration & dosage
- Ophthalmic Solutions -- administration & dosage
- Peripheral Nervous System Diseases -- chemically induced
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prednisone -- administration & dosage
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.